ProCE Banner Activity

Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment

Podcast Episodes

In this podcast episode, listen to expert faculty perspectives on HDV management, including their approach to complex clinical cases, staging liver disease, and screening for hepatocellular carcinoma.

Released: June 19, 2023

Share

Faculty

Nancy Reau

Nancy Reau, MD

Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center 
Chicago, Illinois

Heiner Wedemeyer

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and Janssen Therapeutics Division of Janssen Products.

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Disclosure

Primary Author

Nancy Reau, MD

Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center 
Chicago, Illinois

Nancy Reau, MD: consultant/advisor: AbbVie, Antios, Arbutus, Gilead, Intercept, Salix; researcher: AbbVie, Gilead, Intercept.

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Heiner Wedemeyer, MD: consultant/advisor/speaker: Falk, Gilead, GlaxoSmithKline, Janssen, Merck Sharp and Dohme, Roche, Vir Pharmaceuticals; researcher: Biotest.